Pact eyes Asian expansion
The market has been unimpressed with Pact since it floated late last year, but there's growth potential in Asia's expanding middle class.
Silex: Fission for opportunity
A small Australian technology business could turn the nuclear industry on its head and, in doing so, could make investors rich.
Acrux: The bear case
Acrux is the second most shorted stock on the ASX but, as Graham Witcomb explains, the bear case doesn't stack up.
Odell bets his reputation
Jamie Odell is gambling his reputation on a ‘transformational’ acquisition in the US. Given the liberal use of debt to finance it, the stakes are high.
Healthscope in the waiting room
Australia’s second largest hospital operator is ready to list at a steep discount to its major competitor. Deal or no deal?
Your small-cap healthcare portfolio
Australia’s population isn’t getting any younger, but there’s a silver lining for investors who take a leaf from venture capital.
Brickworks: Low margin, high returns?
Following a tour of Brickworks facilities with management, Gaurav Sodhi gets an insider’s view of the building materials business.
Screwed by the 'CAN' bank?
It’s estimated up to 400,000 people could be affected by CBA’s deficient financial advice. If you’re one of them, here’s what you need to know.
Super Retail Group vs. The Reject Shop
When rolling out new stores, success may hinge on whether you sell tents or toiletries. Do you know which is better?
Fleetwood going for a song
The company's key asset is generating lower profit and this is unlikely to change. But low expectations are now reflected in the share price.
Call 1300 880 160
Start a chat
Schedule a call
